Cytokinetics Inc (CYTK): Depreciation & Amortization
$10.12M
Year ended 2025-12-31
$12.55M
Trailing 12 months to 2026-06-30
+20.3%
3-year compound annual growth
+40.8%
5-year compound annual growth
+32.9%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.12M | +6.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $9.53M | -19.9% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $11.89M | +104.5% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $5.81M | +155.4% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $2.28M | +24.3% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $1.83M | +41.6% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $1.29M | +4.4% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $1.24M | -35.5% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $1.92M | +159.1% | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | $741.0K | +25.8% | 2018-03-05, From 2016-01-01 |
| 2015-12-31 | $589.0K | +20.2% | 2018-03-05, From 2015-01-01 |
| 2014-12-31 | $490.0K | +13.2% | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | $433.0K | -26.7% | 2016-03-03, From 2013-01-01 |
| 2012-12-31 | $591.0K | -54.4% | 2015-03-06, From 2012-01-01 |
| 2011-12-31 | $1.30M | -31.7% | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | $1.90M | -6.0% | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | $2.02M | n/a | 2012-03-13, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | 2025-12-31 | $10.12M | +6.2% |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $9.26M | -26.0% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $1.37M | n/m |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $8.74M | -6.2% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $3.02M | -14.6% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $562.6K | +4.5% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $4.04M | +252.9% |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $4.05M | -36.5% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $6.42M | -10.5% |
Compare CYTK, LAB, SPRY, NRIX side by side · Screen every company in Pharmaceutical Preparations ↗